Decoding the role of coiled-coil motifs in human prion-like proteins

References

• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136–144.
   PubMed Web of Science ®Google Scholar
• Gil-Garcia M, Iglesias V, Pallares I, et al. Prion-like proteins: from computational approaches to proteome-wide analysis. FEBS open bio. 2021 May 31.1-12. doi: https://doi.org/10.1002/2211-5463.13213
   Google Scholar
• Batlle C, Calvo I, Iglesias V, et al. MED15 prion-like domain forms a coiled-coil responsible for its amyloid conversion and propagation. Commun Biol. 2021;4(1):414.
   PubMed Web of Science ®Google Scholar
• Batlle C, Iglesias V, Navarro S, et al. Prion-like proteins and their computational identification in proteomes. Expert Rev Proteomic. 2017;14(4):335–350.
   PubMed Web of Science ®Google Scholar
• Wickner RB, Edskes HK, Shewmaker F, et al. Prions of fungi: inherited structures and biological roles. Nature Rev Microbiol. 2007;5(8):611–618.
   PubMed Web of Science ®Google Scholar
• Gemayel R, Chavali S, Pougach K, et al. Variable glutamine-rich repeats modulate transcription factor activity. Mol Cell. 2015;59(4):615–627.
   PubMed Web of Science ®Google Scholar
• Fiumara F, Fioriti L, Kandel ER, et al. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins. Cell. 2010;143(7):1121–1135.
   PubMed Web of Science ®Google Scholar
• Iglesias V, Paladin L, Juan-Blanco T, et al. In silico characterization of human prion-like proteins: beyond neurological diseases. Front Physiol. 2019;10:314.
   PubMed Web of Science ®Google Scholar
• Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science. 1991;252(5009):1162–1164.
   PubMed Web of Science ®Google Scholar
• McDonnell AV, Jiang T, Keating AE, et al. Paircoil2: improved prediction of coiled coils from sequence. Bioinformatics. 2006;22(3):356–358.
   PubMed Web of Science ®Google Scholar
• Wang KY, Duan CX, Zou XJ, et al. Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma. Oncol Lett. 2018;15(4):4303–4313.
   PubMed Web of Science ®Google Scholar
• Dragan AI, Privalov PL. Unfolding of a leucine zipper is not a simple two-state transition. J Mol Biol. 2002;321(5):891–908.
   PubMed Web of Science ®Google Scholar
• Constantinescu Aruxandei D, Makbul C, Koturenkiene A, et al. Dimerization-induced folding of MST1 SARAH and the influence of the intrinsically unstructured inhibitory domain: low thermodynamic stability of monomer. Biochemistry. 2011;50(51):10990–11000.
   PubMed Web of Science ®Google Scholar
• Walavalkar NM, Gordon N, Williams DC Jr. Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (MBD2) homologues and GATA zinc finger domain containing 2A (GATAD2A/p66alpha). J Biol Chem. 2013;288(5):3419–3427.
   PubMed Web of Science ®Google Scholar
• Myers JK, Oas TG. Reinterpretation of GCN4-p1 folding kinetics: partial helix formation precedes dimerization in coiled coil folding. J Mol Biol. 1999;289(2):205–209.
   PubMed Web of Science ®Google Scholar
• Zitzewitz JA, Ibarra-Molero B, Fishel DR, et al. Preformed secondary structure drives the association reaction of GCN4-p1, a model coiled-coil system. J Mol Biol. 2000;296(4):1105–1116.
   PubMed Web of Science ®Google Scholar
• Truebestein L, Leonard TA. Coiled-coils: the long and short of it. BioEssays. 2016;38(9):903–916.
   PubMed Web of Science ®Google Scholar
• Ford LK, Fioriti L. Coiled-coil motifs of RNA-binding proteins: dynamicity in RNA regulation. Front Cell Dev Biol. 2020;8:1383.
   Web of Science ®Google Scholar
• Oshea EK, Rutkowski R, Kim PS. Evidence That the Leucine Zipper Is a Coiled Coil. Science. 1989;243(4890):538–542.
   PubMed Web of Science ®Google Scholar
• Miyaji-Yamaguchi M, Okuwaki M, Nagata K. Coiled-coil structure-mediated dimerization of template activating factor-I is critical for its chromatin remodeling activity. J Mol Biol. 1999;290(2):547–557.
   PubMed Web of Science ®Google Scholar
• Matityahu A, Onn I. A new twist in the coil: functions of the coiled-coil domain of structural maintenance of chromosome (SMC) proteins. Curr Genet. 2018;64(1):109–116.
   PubMed Web of Science ®Google Scholar
• Petrovic A, Keller J, Liu YH, et al. Structure of the MIS12 complex and molecular basis of its interaction with CENP-C at human kinetochores. Cell. 2016;167(4):1028-+.
   PubMed Web of Science ®Google Scholar
• Patzke S, Hauge H, Sioud M, et al. Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization. Oncogene. 2005;24(7):1159–1173.
   PubMed Web of Science ®Google Scholar
• Salisbury JL. Centrosomes: coiled-coils organize the cell center. Curr Biol. 2003;13(3):R88–90.
   PubMed Web of Science ®Google Scholar
• Rose A, Schraegle SJ, Stahlberg EA, et al. Coiled-coil protein composition of 22 proteomes–differences and common themes in subcellular infrastructure and traffic control. BMC Evol Biol. 2005;5(1):66.
   PubMedGoogle Scholar
• Maculins T, Garcia-Pardo J, Skenderovic A, et al. Discovery of protein-protein interaction inhibitors by integrating protein engineering and chemical screening platforms. Cell Chem Biol. 2020;27(11):1441–1451 e7.
   PubMed Web of Science ®Google Scholar
• Rahighi S, Ikeda F, Kawasaki M, et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell. 2009;136(6):1098–1109.
   PubMed Web of Science ®Google Scholar
• Hartmann MD, Mendler CT, Bassler J, et al. alpha/beta coiled coils. eLife. 2016;5:e11861.
   Web of Science ®Google Scholar
• Dong H, Hartgerink JD. Role of hydrophobic clusters in the stability of alpha-helical coiled coils and their conversion to amyloid-like beta-sheets. Biomacromolecules. 2007;8(2):617–623.
   PubMed Web of Science ®Google Scholar
• Huang S, Jj L, Yang S, et al. Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor. Brain. 2011;134(7):1943–1958.
   PubMedGoogle Scholar
• Purrello M, Di Pietro C, Mirabile E, et al. Physical mapping at 6q27 of the locus for the TATA box-binding protein, the DNA-binding subunit of TFIID and a component of SL1 and TFIIIB, strongly suggests that it is single copy in the human genome. Genomics. 1994;22(1):94–100.
   PubMed Web of Science ®Google Scholar
• Lescure A, Lutz Y, Eberhard D, et al. The N‐terminal domain of the human TATA‐binding protein plays a role in transcription from TATA‐containing RNA polymerase II and III promoters. EMBO J. 1994;13(5):1166–1175.
   PubMed Web of Science ®Google Scholar
• Reid SJ, Rees MI, van Roon-Mom WM, et al. Molecular investigation of TBP allele length:: a SCA17 cellular model and population study. Neurobiol Dis. 2003;13(1):37–45.
   PubMed Web of Science ®Google Scholar
• Lancaster AK, Nutter-Upham A, Lindquist S, et al. PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition. Bioinformatics. 2014;30(17):2501–2502.
   PubMed Web of Science ®Google Scholar
• Zhao X, Herr W. A regulated two-step mechanism of TBP binding to DNA: a solvent-exposed surface of TBP inhibits TATA box recognition. Cell. 2002;108(5):615–627.
   PubMed Web of Science ®Google Scholar
• Patel AB, Louder RK, Greber BJ, et al. Structure of human TFIID and mechanism of TBP loading onto promoter DNA. Science. 2018;362(6421):6421.
   Web of Science ®Google Scholar
• Takahashi J, Fukuda T, Tanaka J, et al. Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol. 2000;99(5):589–594.
   PubMed Web of Science ®Google Scholar
• Uchihara T, Fujigasaki H, Koyano S, et al. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias–triple-labeling immunofluorescence study. Acta Neuropathol. 2001;102(2):149–152.
   PubMed Web of Science ®Google Scholar
• Perez MK, Paulson HL, Pendse SJ, et al. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol. 1998;143(6):1457–1470.
   PubMed Web of Science ®Google Scholar
• van Roon-Mom WM, Reid SJ, Jones AL, et al. Insoluble TATA-binding protein accumulation in Huntington’s disease cortex. Mol Brain Res. 2002;109(1–2):1–10.
   PubMedGoogle Scholar
• Reid SJ, van Roon-Mom WM, Wood PC, et al. TBP, a polyglutamine tract containing protein, accumulates in Alzheimer’s disease. Mol Brain Res. 2004;125(1–2):120–128.
   PubMedGoogle Scholar
• Nakamura K, Jeong S-Y, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet. 2001;10(14):1441–1448.
   PubMed Web of Science ®Google Scholar
• van Roon-Mom W, Reid S, Faull R, et al. TATA-binding protein in neurodegenerative disease. Neuroscience. 2005;133(4):863–872.
   PubMed Web of Science ®Google Scholar
• Nolte D, Sobanski E, Wissen A, et al. Spinocerebellar ataxia type 17 associated with an expansion of 42 glutamine residues in TATA-box binding protein gene. J Neurol Neurosurg. 2010;81(12):1396–1399.
   Web of Science ®Google Scholar
• Sabate R, Rousseau F, Schymkowitz J, et al. What makes a protein sequence a prion? PLoS Comput Biol. 2015;11(1):e1004013.
   PubMed Web of Science ®Google Scholar
• Chan HM, La Thangue NB. p300/CBP proteins: hATs for transcriptional bridges and scaffolds. J Cell Sci. 2001;114(13):2363–2373.
   PubMed Web of Science ®Google Scholar
• Mantamadiotis T, Lemberger T, Bleckmann SC, et al. Disruption of CREB function in brain leads to neurodegeneration. Nat Genet. 2002;31(1):47–54.
   PubMed Web of Science ®Google Scholar
• Giordano A, Avantaggiati ML. p300 and CBP: partners for life and death. J Cell Physiol. 1999;181(2):218–230.
   PubMed Web of Science ®Google Scholar
• Heery DM, Kalkhoven E, Hoare S, et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997;387(6634):733–736.
   PubMed Web of Science ®Google Scholar
• Plevin MJ, Mills MM, Ikura M. The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem Sci. 2005;30(2):66–69.
   PubMed Web of Science ®Google Scholar
• Sheppard HM, Harries JC, Hussain S, et al. Analysis of the steroid receptor coactivator 1 (SRC1)-CREB binding protein interaction interface and its importance for the function of SRC1. Mol Cell Biol. 2001;21(1):39–50.
   PubMed Web of Science ®Google Scholar
• Nucifora FC, Sasaki M, Peters MF, et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001;291(5512):2423–2428.
   PubMed Web of Science ®Google Scholar
• McCampbell A, Taylor JP, Taye AA, et al. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet. 2000;9(14):2197–2202.
   PubMed Web of Science ®Google Scholar
• Steffan JS, Bodai L, Pallos J, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001;413(6857):739–743.
   PubMed Web of Science ®Google Scholar
• Rouaux C, J-p L, Boutillier A-L. Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem Pharmacol. 2004;68(6):1157–1164.
   PubMed Web of Science ®Google Scholar
• McCampbell A, Taye AA, Whitty L, et al. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci USA2001;98( 26):15179–15184.
   Google Scholar
• Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):1–21.
   PubMedGoogle Scholar
• Tsai -C-C, Kao H-Y, Mitzutani A, et al. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc Natl Acad Sci USA . 2004;101( 12):4047–4052.
   Google Scholar
• Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30(1):575–621.
   PubMedGoogle Scholar
• Rocha S, Vieira J, Vázquez N, et al. ATXN1 N-terminal region explains the binding differences of wild-type and expanded forms. BMC Med Genomics. 2019;12(1):1–14.
   PubMed Web of Science ®Google Scholar
• Irwin S, Vandelft M, Pinchev D, et al. RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci. 2005;118(1):233–242.
   PubMed Web of Science ®Google Scholar
• Gennarino VA, Singh RK, White JJ, et al. Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 2015;160(6):1087–1098.
   PubMed Web of Science ®Google Scholar
• Nitschke L, Tewari A, Coffin SL, et al. miR760 regulates ATXN1 levels via interaction with its 5′ untranslated region. Genes Dev. 2020;34(17–18):1147–1160.
   PubMed Web of Science ®Google Scholar
• Park J, Al-Ramahi I, Tan Q, et al. RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature. 2013;498(7454):325–331.
   PubMed Web of Science ®Google Scholar
• Friedrich J, Kordasiewicz HB, O’Callaghan B, et al. Antisense oligonucleotide–mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI Insight. 2018;3(21):21.
   Web of Science ®Google Scholar
• Keiser MS, Boudreau RL, Davidson BL. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy. Mol Ther. 2014;22(3):588–595.
   PubMed Web of Science ®Google Scholar
• Suh J, Romano DM, Nitschke L, et al. Loss of ataxin-1 potentiates Alzheimer’s pathogenesis by elevating cerebral BACE1 transcription. Cell. 2019;178(5):1159–1175. e17.
   PubMed Web of Science ®Google Scholar
• Lee Y, Samaco RC, Gatchel JR, et al. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci. 2008;11(10):1137–1139.
   PubMed Web of Science ®Google Scholar
• Petrakis S, Raskó T, Russ J, et al. Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1. PLoS Genet. 2012;8(8):e1002897.
   PubMed Web of Science ®Google Scholar
• Cuvertino S, Hartill V, Colyer A, et al. A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome. Genet Med. 2020;22(5):867–877.
   PubMed Web of Science ®Google Scholar
• Prives C, Lowe SW. Mutant p53 and chromatin regulation. Nature. 2015;525(7568):199–200.
   PubMed Web of Science ®Google Scholar
• Zhang J, Dominguez-Sola D, Hussein S, et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med. 2015;21(10):1190.
   PubMed Web of Science ®Google Scholar
• Lee J-E, Wang C, Xu S, et al. H3K4 mono-and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation. eLife. 2013;2:e01503.
   PubMed Web of Science ®Google Scholar
• Boniel S, Szymańska K, Śmigiel R, et al. Kabuki syndrome—clinical review with molecular aspects. Genes (Basel). 2021;12(4):468.
   PubMed Web of Science ®Google Scholar
• Ortega-Molina A, Boss IW, Canela A, et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med. 2015;21(10):1199.
   PubMed Web of Science ®Google Scholar
• Cheon CK, Sohn YB, Ko JM, et al. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome. J Hum Genet. 2014;59(6):321–325.
   PubMed Web of Science ®Google Scholar
• Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42(9):790–793.
   PubMed Web of Science ®Google Scholar
• Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013;498(7453):220–223.
   PubMed Web of Science ®Google Scholar
• Hannibal MC, Buckingham KJ, Ng SB, et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet Part A. 2011;155(7):1511–1516.
   Google Scholar
• Fisher SE. A molecular genetic perspective on speech and language. In G. Hickok & S. Small (Eds.), Neurobiology of language: Elsevier. Amsterdam. 2016. p. 13–24.
   Google Scholar
• Marcus GF, Fisher SE. FOXP2 in focus: what can genes tell us about speech and language? Trends Cogn Sci. 2003;7(6):257–262.
   PubMed Web of Science ®Google Scholar
• Fisher SE, Scharff C. FOXP2 as a molecular window into speech and language. Trends Genet. 2009;25(4):166–177.
   PubMed Web of Science ®Google Scholar
• Tsui D, Vessey JP, Tomita H, et al. FoxP2 regulates neurogenesis during embryonic cortical development. J Neurosci. 2013;33(1):244–258.
   PubMed Web of Science ®Google Scholar
• Chiu YC, Li MY, Liu YH, et al. Foxp2 regulates neuronal differentiation and neuronal subtype specification. Dev Neurobiol. 2014;74(7):723–738.
   PubMed Web of Science ®Google Scholar
• Clovis YM, Enard W, Marinaro F, et al. Convergent repression of Foxp2 3′UTR by miR-9 and miR-132 in embryonic mouse neocortex: implications for radial migration of neurons. Development. 2012;139(18):3332–3342.
   PubMed Web of Science ®Google Scholar
• Mukamel Z, Konopka G, Wexler E, et al. Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. J Neurosci. 2011;31(32):11437–11442.
   PubMed Web of Science ®Google Scholar
• Lai CS, Fisher SE, Hurst JA, et al. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001;413(6855):519–523.
   PubMed Web of Science ®Google Scholar
• Lieberman P. FOXP2 and human cognition. Cell. 2009;137(5):800–802.
   PubMed Web of Science ®Google Scholar
• Herrero MJ, Gitton Y. The untold stories of the speech gene, the FOXP2 cancer gene. Genes Cancer. 2018;9(1–2):11.
   PubMedGoogle Scholar
• Li S, Weidenfeld J, Morrisey EE. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol. 2004;24(2):809–822.
   PubMed Web of Science ®Google Scholar
• Häußermann K, Young G, Kukura P, et al. Dissecting FOXP2 oligomerization and DNA binding. Angew Chem. 2019;131(23):7744–7749.
   Google Scholar
• Stroud JC, Wu Y, Bates DL, et al. Structure of the forkhead domain of FOXP2 bound to DNA. Structure. 2006;14(1):159–166.
   PubMed Web of Science ®Google Scholar
• Mizutani A, Matsuzaki A, Momoi MY, et al. Intracellular distribution of a speech/language disorder associated FOXP2 mutant. Biochem Biophys Res Commun. 2007;353(4):869–874.
   PubMed Web of Science ®Google Scholar